Chemokines and interleukin-18 are up-regulated in bronchoalveolar lavage fluid but not in serum of septic surgical ICU patients

Shock

Volumn 15, Issue 3, 2001, Pages 176-180

  Mathiak, Guenther ^a,c   Neville, Lewis F ^b   Grass, Guido ^a   Boehm, Sebastian A ^a   Luebke, Thomas ^a   Herzmann, Thomas ^a   Kabir, Koroush ^a   Rosendahl, Ralf ^a   Schaefer, Ute ^a   Mueller, Carola ^a   Bohlen, Heribert ^d   Wassermann, Klaus ^d   Hoelscher, Arnulf H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b XTL Biopharmaceuticals Ltd Israel   (Israel)

^c UNIVERSITY OF BONN   (Germany)

^d NONE

Author keywords

Compartmentalization; Interleukin 18; Lung; SIRS

Indexed keywords

CHEMOKINE; INTERLEUKIN 18; INTERLEUKIN 6; MESSENGER RNA;

ARTICLE; BLOOD; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; INTENSIVE CARE; LUNG LAVAGE; METABOLISM; POSTOPERATIVE COMPLICATION; SEPSIS; UPREGULATION;

BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CHEMOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTENSIVE CARE; INTERLEUKIN-18; INTERLEUKIN-6; POSTOPERATIVE COMPLICATIONS; RNA, MESSENGER; SEPSIS; UP-REGULATION;

EID: 0035292648     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200115030-00003     Document Type: Article

References (27)

1. Neugebauer E, Rixen D, Raum M, Schäfer W: Thirty years of anti-mediator treatment in sepsis and septic-shock what have we learned? Langenbecks Arch Surg 383:26-34, 1998.
2. Friedman G, Silva E, Vincent JL: Has the mortality of septic shock changed with time? Crit Care Med 26:2078-2086, 1998.
3. Deitch EA: Animal models of sepsis and shock: a review and lessons learned. Shock 9:1-11, 1998.
4. Presterl E, Staudinger T, Pettermann M, Lassnigg A, Burgmann H, Winkler S, Frass M, Granninger W: Cytokine profile and correlation to the APACHE III and MPM II Scores in patients with sepsis. Am J Respir Crit Care Med 156: 825-832, 1997.
5. Rabinovici R, John R, Esser KM, Vernick J, Feuerstein G: Serum tumor necrosis factor alpha profile in trauma patients. J Trauma 35:698-702, 1993.
6. Puren AJ, Fantuzzi G, Gu Y, Su MSS, Dinarello CA: Inteleukin-18 (IFNμ-inducing factor) induces IL-8 and IL-1β via TNFα production from non-CD14+ human blood molecular cells. J Clin Investig 101:711-721, 1998.
7. Dinarello CA: IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103(Pt. 1):11-24, 1999.
8. Gillespie MT, Horwood NJ: Interleukin-18: perspectives on the newest interleukin. Cytokine Growth Factor Rev 9:109-116, 1998.
9. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physician/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992.
10. Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL: Patterns of cytokine evolution (tumor necrosis factor-α and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 25:1813-1819, 1997.
11. Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A: Change in the ration of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 27: 1262-1264, 1999.
12. Neville LF, Abdullah F, McDonnell PM, Young PR, Feuerstein GZ, Rabinovici R: mob-1 expression in IL-2-induced ARDS: regulation by TNF-α. Am J Physiol 269:L884-L890, 1995.
13. Inwald DP, Costeloe K, Murch SH: High concentrations of GRO-α and MCP-1 in bronchoalveolar fluid of infants with respiratory distress syndrome after surfactant. Arch Dis Child Fetal Neonatal Ed 73:F234-F235, 1998.
14. Montón C, Torres A, El-Ebiary M, Filella X, Xaubet A, de la Bellacasa JP: Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med 27:1745-1753, 1999.
15. Kohno K, Kurimoto M: Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both. Clin Immunol Immunopathol 86:11-15, 1998.
16. Tanigushi M, Nagaoka K, Kunikata T, Kayano T, Yamauchi H, Nakamura S, Ikeda M, Orita K, Kurimuto M: Characterization of anti-human interleukin-18 (IL-18)/interferon-γ-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA. J Immunol Methods 206:107-113, 1997.
17. Lauw FN, Simpson JH, Prins JM, Smith MD, Kurimoto M, van Denventer SJH, Speelman P, Chaowagul W, White NJ, van der Poll T: Elevated plasma concentrations of interferon (IFN)-γ and the IFN-g-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis. J Infect Dis 180:1878-1885, 1999.
18. Novick D., Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M: Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10:127-136, 1999.
19. Bossink AWJ, Paemen L, Jansen PM, Hack E, Tijs LG, van Damme J: Plasma levels of the chemokines monocytic proteins-1 and -2 are elevated in human sepsis. Blood 86:3841-3847, 1995.
20. O'Grady NP, Tropea M, Preas HL, Reda D, Vandivier RW, Banks SM, Suffredini AF: Detection of macrophage inflammatory protein (MIP)-1α and MIP-1β during experimental endotoxemia and human sepsis. J Infect Dis 179: 136-141, 1999.
21. Jansen PM, van Damme J, Put W, de Jong IW, Taylor FB, Hack C. E.: Monocyte chemotactic protein 1 is release during lethal and sublethal bacteremia in baboons. J Infect Dis 171:1640-1642, 1995.
22. Luster Ad: Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 338:436-445, 1998.
23. Kurdowska A, Miller EJ, Noble JM, Baugham RP, Matthay MA, Brelsford WG, Cohen AB: Anti-IL-8 auto-antibodies in alveolar fluid from patients with the adult respiratory distress syndrome. J Immunol 157:2699-2706, 1996.
24. Knapp S, Thalhammer LGJ, Laczika K, Hollenstein U, Frass M,WS, Stoiser B, Wilfing A, Burgmann H: Prognostic value of MIP-1α, TGF-β2, sELAM-1, and sVCAM-1 in patients with gram-positive sepsis. Clin Immun Immunopathol 87:139-144, 1998.
25. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ: Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 268:12247-12249, 1992.
26. Marie C, Fitting C, Cheval C, Losser MR, Carlet J, Payen D, Foster K, Cavaillon JM: Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome. Infect Immunol 65:865-817, 1997.
27. Mathiak G, Szcewczyk D, Abdullah F, Ovadia P, Feuerstein G, Rabinovici R: An improved clinically relevant sepsis model in the conscious rat. Crit Care Med 28:1947-1952, 2000.